Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation (Q35915899)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 October 2011

Language	Label	Description	Also known as
English	Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation	scientific article published on 18 October 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

4

object named as

Wing C Chan

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

James O Armitage

12

object named as

James O Armitage

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

13

object named as

Julie M Vose

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Dennis D Weisenburger

2

object named as

Dennis D Weisenburger

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Timothy Greiner

5

object named as

Timothy C Greiner

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

6

object named as

Patricia Aoun

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Philip J Bierman

11

object named as

Philip J Bierman

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

R Gregory Bociek

10

object named as

R Gregory Bociek

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Keni Gu

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Kai Fu

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Lynette M Smith

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Martin Bast

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Zhongfen Liu

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

18 October 2011

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Hematological Oncology

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

30

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

143-149

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

11 July 2018

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.1017

21 January 2018

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

1 reference

https://api.crossref.org/works/10.1002%2FHON.1017

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.1017

21 January 2018

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

1 reference

https://api.crossref.org/works/10.1002%2FHON.1017

21 January 2018

Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.

1 reference

https://api.crossref.org/works/10.1002%2FHON.1017

21 January 2018

Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHON.1017

21 January 2018

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.1017

21 January 2018

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.1017

21 January 2018

High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524810

24 September 2018

Prognostic impact of diffuse large B-cell lymphoma subgroups in patients undergoing autologous SCT

1 reference

https://pubmed.ncbi.nlm.nih.gov/22009820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22009820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/22009820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of MIME salvage regimen for recurrent or refractory lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22009820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/HON.1017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35915899&oldid=1858064657"